Study of Vilazodone to Treat Social Anxiety Disorder

• Status: Unknown status
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Vilazodone is effective in the treatment of symptoms of Social Anxiety Disorder among adults.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Medical Research Network
• Collaborator: Forest Laboratories
• Treatments: Vilazodone Hydrochloride

Criteria

Inclusion Criteria:

• Diagnosis of Social Anxiety Disorder, generalized subtype

• LSAS total score of 70 at visits 1 and 2

Exclusion Criteria:

• Lifetime history of Bipolar disorder or Schizophrenia

• Current suicidal risk

• Current unstable medical condition